05/08/2024
6:05 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
6:07 AM | Marinus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024
4:51 PM | CITADEL ADVISORS LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G | |
04/19/2024
5:04 AM | Marinus Pharmaceuticals (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
| Form SC 13G | |
04/15/2024
6:32 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
7:00 AM | Marinus Pharmaceuticals (Filer)
| Form DEF 14A | |
04/04/2024
7:02 AM | Marinus Pharmaceuticals (Filer)
| Form DEFA14A | |
|
03/27/2024
10:55 AM | Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
11:18 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024
9:35 AM | Marinus Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
| Form SC 13G | |
02/14/2024
8:04 AM | Avoro Capital Advisors LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/13/2024
11:13 AM | Marinus Pharmaceuticals (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/08/2024
12:56 PM | JENNISON ASSOCIATES LLC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G | |
02/07/2024
6:25 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/06/2024
10:58 AM | FRANKLIN RESOURCES INC (Filed by)
Marinus Pharmaceuticals (Subject)
| Form SC 13G | |
01/19/2024
3:18 PM | Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:19 PM | Marinus Pharmaceuticals (Issuer)
Pfanstiel Steven (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:20 PM | Hulihan Joseph (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:21 PM | MANNING MARTHA E (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:21 PM | Marinus Pharmaceuticals (Issuer)
Shafer Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:22 PM | Marinus Pharmaceuticals (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:23 PM | Austin Charles (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:23 PM | Marinus Pharmaceuticals (Issuer)
Nochur Sara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:25 PM | Fischer Seth H. Z. (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:26 PM | Ezickson Elan (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:27 PM | Marinus Pharmaceuticals (Issuer)
Silverstein Christine Berni (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:27 PM | Johnson Marvin (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:28 PM | Marinus Pharmaceuticals (Issuer)
Noonberg Sarah B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
6:04 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/28/2023
6:05 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
6:31 AM | Marinus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
6:11 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/28/2023
6:05 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2023
7:02 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2023
6:00 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2023
6:00 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
6:55 AM | Marinus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023
6:10 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
8:05 PM | Hulihan Joseph (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2023
8:05 PM | MANNING MARTHA E (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2023
8:05 PM | Marinus Pharmaceuticals (Issuer)
Pfanstiel Steven (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
READ THIS – If You Missed Out On The AI Boom (Ad) Adam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy.
Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.” Click on Adam's shiny forehead for more details. |
08/08/2023
8:05 PM | Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2023
8:05 PM | Marinus Pharmaceuticals (Issuer)
Shafer Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
7:45 AM | Marinus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2023
8:02 PM | Marinus Pharmaceuticals (Issuer)
Noonberg Sarah B. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/17/2023
8:08 PM | Marinus Pharmaceuticals (Issuer)
Noonberg Sarah B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
